BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12878989)

  • 1. Ultrasonic analysis of anthracycline-induced myocardial damage using cyclic variation of integrated backscatter.
    Nagai H; Omi W; Yuasa T; Sakagami S; Takata S; Kobayashi K
    J Am Soc Echocardiogr; 2003 Aug; 16(8):808-13. PubMed ID: 12878989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular function in patients with toxic cardiomyopathy and with idiopathic dilated cardiomyopathy treated with Doxorubicin.
    Katamadze NA; Lartsuliani KP; Kiknadze MP
    Georgian Med News; 2009 Jan; (166):43-8. PubMed ID: 19202217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthracycline-induced cardiomyopathies evaluated by tissue Doppler tracking system and strain rate imaging.
    Takenaka K; Kuwada Y; Sonoda M; Uno K; Asakawa M; Sakurai S; Takahashi T; Sasaki K; Matsuzaki M; Kikuchi A; Amagai R; Furudate N; Nagai R
    J Cardiol; 2001; 37 Suppl 1():129-32. PubMed ID: 11433816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors.
    Amigoni M; Giannattasio C; Fraschini D; Galbiati M; Capra AC; Madotto F; Cesana F; Jankovic M; Masera G; Mancia G
    Pediatr Blood Cancer; 2010 Dec; 55(7):1343-7. PubMed ID: 20589666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early detection of anthracyclines cardiotoxicity by tissue Doppler echocardiography about 45 cases at Abidjan institute of cardiology].
    Pio M; Adoubi K; Adoh A; Didi-Kouko C; Anzouan-Kacou JB; Tegnan A; Adoubi I
    Ann Cardiol Angeiol (Paris); 2013 Feb; 62(1):28-33. PubMed ID: 22513244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of anthracycline-induced cardiotoxicity by radionuclide angiocardiography.
    Suzuki J; Yanagisawa A; Shigeyama T; Tsubota J; Yasumura T; Shimoyama K; Ishikawa K
    Angiology; 1999 Jan; 50(1):37-45. PubMed ID: 9924887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive early detection of anthracycline-induced cardiotoxicity in patients with hematologic malignancies using the phased tracking method.
    Saito Y; Susukida I; Uzuka Y; Kanai H
    Cancer Med; 2016 Sep; 5(9):2276-85. PubMed ID: 27484957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients.
    Nousiainen T; Vanninen E; Jantunen E; Remes J; Ritanen E; Vuolteenaho O; Hartikainen J
    Clin Sci (Lond); 2001 Dec; 101(6):601-7. PubMed ID: 11724646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of latent anthracycline-induced cardiotoxicity using left ventricular end-systolic wall stress-velocity of circumferential fiber-shortening relationship.
    Mizuno R; Fujimoto S; Saito Y; Okamoto Y
    Heart Vessels; 2014 May; 29(3):384-9. PubMed ID: 23780325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy.
    Tsai HR; Gjesdal O; Wethal T; Haugaa KH; Fosså A; Fosså SD; Edvardsen T
    Am J Cardiol; 2011 Feb; 107(3):472-7. PubMed ID: 21257017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of carvedilol against anthracycline-induced cardiomyopathy.
    Kalay N; Basar E; Ozdogru I; Er O; Cetinkaya Y; Dogan A; Inanc T; Oguzhan A; Eryol NK; Topsakal R; Ergin A
    J Am Coll Cardiol; 2006 Dec; 48(11):2258-62. PubMed ID: 17161256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.
    Hequet O; Le QH; Moullet I; Pauli E; Salles G; Espinouse D; Dumontet C; Thieblemont C; Arnaud P; Antal D; Bouafia F; Coiffier B
    J Clin Oncol; 2004 May; 22(10):1864-71. PubMed ID: 15143078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of early manifestations of myocardial dysfunction at early stages of antitumor treatment in patients with lymphogranulomatosis and lymphosarcomas].
    Iskhakov ED; Sakhibov IaD; Migunova EV; Sagdieva NSh; Glasko EN; Kaplanskaia IB; Atopkov BA; Model SV; Korolev AA; Gemdzhian EG
    Ter Arkh; 2007; 79(4):42-6. PubMed ID: 17564017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery from anthracycline cardiomyopathy--how can it be explained?
    Christiansen S
    J Heart Lung Transplant; 2009 Jul; 28(7):751. PubMed ID: 19560709
    [No Abstract]   [Full Text] [Related]  

  • 15. Ventricular repolarization time indexes following anthracycline treatment.
    Sarubbi B; Orditura M; Ducceschi V; De Vita F; Santangelo L; Ciaramella F; Catalano G; Iacono A
    Heart Vessels; 1997; 12(6):262-6. PubMed ID: 9860192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.
    Cardinale D; Colombo A; Bacchiani G; Tedeschi I; Meroni CA; Veglia F; Civelli M; Lamantia G; Colombo N; Curigliano G; Fiorentini C; Cipolla CM
    Circulation; 2015 Jun; 131(22):1981-8. PubMed ID: 25948538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular systolic reserve in asymptomatic children previously treated with low doses of anthracyclines.
    Guimaraes-Filho F; Tan D; Braga J; Rodrigues A; Waib P; Matsubara B
    Am J Cardiol; 2007 Oct; 100(8):1303-6. PubMed ID: 17920375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automatic border detection identifies subclinical anthracycline cardiotoxicity in children with malignancy.
    Hashimoto I; Ichida F; Miura M; Okabe T; Kanegane H; Uese K; Hamamichi Y; Misaki T; Koizumi S; Miyawaki T
    Circulation; 1999 May; 99(18):2367-70. PubMed ID: 10318655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular systolic reserve in asymptomatic children previously treated with low doses of anthracyclines: a longitudinal, prospective exercise echocardiography study.
    Guimaraes-Filho FV; Tan DM; Braga JC; Rodrigues A; Waib PH; Matsubara BB
    Pediatr Blood Cancer; 2012 Sep; 59(3):548-52. PubMed ID: 22970439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography.
    Villani F; Meazza R; Materazzo C
    Anticancer Res; 2006; 26(1B):797-801. PubMed ID: 16739356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.